Hier können Sie neue Beiträge via E-Mail abonnieren:

Sie werden zukünftig per E-Mail benachrichtigt, wenn wir einen neuen Beitrag veröffentlichen.


Progress and Challenges for Hematology Centers and Pharmaceutical Manufacturers

In recent years, a number of promising therapeutic approaches have been developed for multiple myeloma (MM). What challenges do they pose for medical specialists and research companies? Oncologist Prof. Dr. Heinz Ludwig (HL), head of the Wilhelminian Cancer Research Institute, Vienna, in conversation with Dr. Thomas Schnelle (TS), Partner at Metaplan.   TS: Over the […]

Read More…